Andrew L. Kung

Andrew L. Kung

Auto-generated profile, based on publicly available information

Andrew L. Kung

Department of Pediatrics, Memorial Sloan Kettering Cancer Center, New York, New York, USA

Research Focus & Metrics

Academic Career Length

37Years (1990-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
24 September 2010 in Nature
Verified
Journal Article
Open access
PDF file
PFPanagis Filippakopoulos
Panagis Filippakopoulos
JQJun Qi
Jun Qi
SPSarah Picaud
Sarah Picaud
YSYao Shen
Yao Shen
WSWilliam B. Smith
William B. Smith
JBJames E. Bradner
James E. Bradner
Epigenetic proteins are intently pursued targets in ligand discovery. So far, successful efforts have been limited to chromatin modifying enzymes, or so-called epigenetic ‘writers’ and ‘erasers’. Potent inhibitors of histone binding modules have not yet been described. Here we report a cell-permeable small molecule (JQ1) that binds competitively to acetyl-lysine recognition motifs, or bromodomains. High potency and specificity towards a subset of human bromodomains is explained by co-crystal structures with bromodomain and extra-terminal (BET) family member BRD4, revealing excellent shape complementarity with the acetyl-lysine binding cavity. Recurrent translocation of BRD4 is observed in a genetically-defined, incurable subtype of human squamous carcinoma. Competitive binding by JQ1 displaces the BRD4 fusion oncoprotein from chromatin, prompting squamous differentiation and specific antiproliferative effects in BRD4-dependent cell lines and patient-derived xenograft models. These data establish proof-of-concept for targeting protein–protein interactions of epigenetic ‘readers’, and provide a versatile chemical scaffold for the development of chemical probes more broadly throughout the bromodomain family.

1 September 2011 in Cell
Verified
Journal Article
Closed access
JDJake E. Delmore
Jake E. Delmore
GIGhayas C. Issa
Ghayas C. Issa
MLMadeleine E. Lemieux
Madeleine E. Lemieux
PRPeter B. Rahl
Peter B. Rahl
JSJunwei Shi
Junwei Shi
CMConstantine Mitsiades
Constantine Mitsiades

1 February 2005 in Cancer Cell
Verified
Journal Article
Closed access
EWEllen Weisberg
Ellen Weisberg
PMPaul W. Manley
Paul W. Manley
WBWerner Breitenstein
Werner Breitenstein
JBJosef Brüggen
Josef Brüggen
SCSandra W. Cowan-Jacob
Sandra W. Cowan-Jacob
JGJames D. Griffin
James D. Griffin

3 September 2004 in Science
Verified
Journal Article
Closed access
PDF file
LWLoren D. Walensky
Loren D. Walensky
AKAndrew L. Kung
Andrew L. Kung
IEIris Escher
Iris Escher
TMThomas J. Malia
Thomas J. Malia
SBScott Barbuto
Scott Barbuto
SKStanley J. Korsmeyer
Stanley J. Korsmeyer
BCL-2 family proteins constitute a critical control point for the regulation of apoptosis. Protein interaction between BCL-2 members is a prominent mechanism of control and is mediated through the amphipathic α-helical BH3 segment, an essential death domain. We used a chemical strategy, termed hydrocarbon stapling, to generate BH3 peptides with improved pharmacologic properties. The stapled peptides, called “stabilized alpha-helix of BCL-2 domains” (SAHBs), proved to be helical, protease-resistant, and cell-permeable molecules that bound with increased affinity to multidomain BCL-2 member pockets. A SAHB of the BH3 domain from the BID protein specifically activated the apoptotic pathway to kill leukemia cells. In addition, SAHB effectively inhibited the growth of human leukemia xenografts in vivo. Hydrocarbon stapling of native peptides may provide a useful strategy for experimental and therapeutic modulation of protein-protein interactions in many signaling pathways.

15 February 2005 in Genes & Development
Verified
Journal Article
Open access
PDF file
CKChryssa Kanellopoulou
Chryssa Kanellopoulou
SMStefan A. Muljo
Stefan A. Muljo
AKAndrew L. Kung
Andrew L. Kung
SGShridar Ganesan
Shridar Ganesan
Ronny DrapkinRonny Drapkin
Ronny Drapkin
KRKlaus Rajewsky
Klaus Rajewsky
Dicer is the enzyme that cleaves double-stranded RNA (dsRNA) into 21–25-nt-long species responsible for sequence-specific RNA-induced gene silencing at the transcriptional, post-transcriptional, or translational level. We disrupted the dicer-1 (dcr-1) gene in mouse embryonic stem (ES) cells by conditional gene targeting and generated Dicer-null ES cells. These cells were viable, despite being completely defective in RNA interference (RNAi) and the generation of microRNAs (miRNAs). However, the mutant ES cells displayed severe defects in differentiation both in vitro and in vivo. Epigenetic silencing of centromeric repeat sequences and the expression of homologous small dsRNAs were markedly reduced. Re-expression of Dicer in the knockout cells rescued these phenotypes. Our data suggest that Dicer participates in multiple, fundamental biological processes in a mammalian organism, ranging from stem cell differentiation to the maintenance of centromeric heterochromatin structure and centromeric silencing.

1 July 2011 in Cancer Cell
Verified
Journal Article
Closed access
SDScott R. Daigle
Scott R. Daigle
EOEdward J. Olhava
Edward J. Olhava
CTCarly A. Therkelsen
Carly A. Therkelsen
CMChristina R. Majer
Christina R. Majer
CSChristopher J. Sneeringer
Christopher J. Sneeringer
RPRoy M. Pollock
Roy M. Pollock